Ipatasertib is under clinical development by Genentech USA and currently in Phase I for Paranasal Sinus And Nasal Cavity Cancer. According to GlobalData, Phase I drugs for Paranasal Sinus And Nasal ...
Stuffy, sneezing, miserable: folks plagued by chronic sinusitis know the feeling all too well. Experts at University of Cincinnati Health say it's also an all-too-common affliction, affecting an ...